Search Results

0 results for 'Office of Device Evaluation of the FDA'

You can use to get even better search results
March 02, 2023 | The Recorder

On the Move: Tracking the Ins and Outs of California Lawyers

New hires, promotions and awards from across the California legal market.
4 minute read
September 15, 2022 | Legaltech News

Dismissal of Virtual Try-On Class Action Illustrates Power of Health Care Exemption as BIPA Defense

A powerful defense has emerged for the targets of VTO suits, and online eyewear retailers in particular—BIPA's health care exemption.
7 minute read
August 01, 2022 | National Law Journal

Arnold & Porter Arrives in Amsterdam With Life Sciences Regs Offering

With a small but growing life sciences sector, the Netherlands has played an increasingly important role in European pharmaceutical regulation ever since the European Medicines Agency moved from London to Amsterdam as a result of Brexit.
5 minute read
December 06, 2021 | National Law Journal

Brown Rudnick Adds FDA Specialist to Global Life Sciences Bench in DC

Neil Di Spirito arrives as the firm strengthens its service offerings to the booming pharmaceutical and biotech sectors.
2 minute read
November 25, 2020 | The Legal Intelligencer

J&J Subsidiary, Investment Firm Agree to $11.5M Whistleblower Settlement Over Cancer Treatment Marketing

The settlement stems from claims brought under the False Claims Act that attorneys from Philadelphia-based Ross Feller Casey initially filed before the government joined the suit.
3 minute read
November 02, 2020 | Legaltech News

Nanotechnology in the Pandemic and What the Future Holds for Regulation

While nanotechnology changes the way we live and work, legal and regulatory frameworks need to zoom in, double-click, and catch up.
7 minute read
October 28, 2020 | Law.com

Amicus Brief on Defense Side Questions Legitimacy of 'Public Nuisance' Theory in Products Liability Cases. Plus: Panel Weighs Appeal of Roundup Verdict

The U.S. Chamber of Commerce and the American Tort Reform Association called the public nuisance case that led to last year's $465 million opioid judgment against Johnson & Johnson a "new species of super tort" that could wipe out swaths of established law.
6 minute read
January 31, 2020 | National Law Journal

Drug and Device Manufacturers Remain in DOJ's Crosshairs

The DOJ continues to make strides in the fraud and abuse sector for life sciences against drug and device manufacturers.
5 minute read
February 09, 2018 | The Legal Intelligencer

Under New DOJ Policy, FDA Guidance Documents Cannot be Used to Prosecute Cases

On Jan. 25, the associate attorney general of the United States issued a policy that prohibits the Department of Justice (DOJ) civil litigators from using guidance documents to establish violations of law in civil enforcement actions.
5 minute read
January 31, 2018 | Insurance Coverage Law Center

10 Workers’ Compensation Trends to Watch in 2018

Here are 10 workers’ compensation trends that insurance and benefits professionals should follow in the coming year. No. 10: The healthcare…
8 minute read

TRENDING STORIES

    Resources

    • Corporate Transparency Act Resource Kit

      Brought to you by Wolters Kluwer

      Download Now

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now